Replacing the existing Wishard Memorial Hospital is so critical to the well-being of the sickly construction sector that one
industry official likens the project to a "lifeline."
Watson Pharmaceuticals filed for FDA approval to sell a low-cost version of Eli Lilly and Co.’s osteoporosis medicine. Indianapolis-based
Lilly is seeking a court order that would block approval until three of its patents expire in 2017.
Clarian will become Indiana University Health early next year in a bet the IU brand carries more punch statewide and nationally.
The Indianapolis-based hospital system, which has 16 hospitals as far afield as LaPorte, Hartford City and Paoli, can
now associate with all its facilities the name of the school that trains the majority of doctors and nurses throughout the
state.
Indiana has now received nearly $50 million in federal bucks to digitize health care around the state. But the latest grant—$16
million to the Indiana Health Information Exchange—comes with specific, ambitious goals for health care providers.
The central Indiana area has been selected as one of 15 communities that will share in $220 million worth of grants for pilot
projects to test health-care information technology.
Ernest Vargo II’s Vargo’s top priority will be guiding the foundation’s $50 million capital campaign for the construction
of the new, $754 million Wishard Hospital.
Anthem Blue Cross withdrew plans to raise health insurance rates for Californians by as much as 39 percent after an independent
audit determined the company’s justification for raising premiums was based on flawed data.
Companion Diagnostics wants to detect early warning signs of chronic diseases.
The university is hoping to find a private company to take over the 5-year-old facility, which formulated and manufactured
small batches of drugs used in clinical trials.
Medco, which operates a major pharmacy and distribution center in Whitestown, got a boost from higher prices on brand-name
drugs and from greater sales of more profitable generic drugs.
The Indianapolis-based health insurer was helped in first quarter by a mild flu season, but it now expects to lose nearly
700,000 customers by year end.
Medicare actuary Richard Foster estimated the new law would raise overall health care spending by an additional $311 million
over current law—more than when he first examined the legislation in December.
The Indianapolis-based health insurer announced Tuesday afternoon it will be the first company to adopt stricter standards
on canceling
policies, which are contained in the health reform bill passed in March.
Purdue University’s decision to close the Chao Center in West Lafayette is a setback for Indiana’s effort to grow
a vibrant contract drug manufacturing sector. But it’s just the latest in a series of unexpected changes—not all for
the worse—since Indianapolis-based BioCrossroads launched a contract drug manufacturing initiative in late 2007.
A federal judge has rejected Guidant Corp.'s guilty plea to charges it hid defects in heart defibrillators, after some
doctors and patients complained about the $296 million deal.
The Purdue Research Foundation says the Chao Center for Industrial Pharmacy and Contract Manufacturing was unable to become
self-sustaining in part because of the recession.
Indianapolis-based health insurer trades jabs with U.S. health secretary after Reuters story claims insurer deliberately cancels
coverage for breast cancer patients.
The two largest U.S. health insurance companies, UnitedHealth, based in Minnetonka, Minn., and WellPoint Inc., based in Indianapolis,
sell Advantage plans.
In January, Anthem Blue Cross notified many individual policyholders that their rates would rise as much as 39 percent March
1. After a public outcry, the company announced a two-month delay. Now that is on hold, too.
